Skip to main content

Advertisement

SpringerLink
Log in

Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lindstrom JM, Einarson BL, Lennon VA, Seybold ME (1976) Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis. J Exp Med 144(3):726–738

    Article  PubMed  CAS  Google Scholar 

  2. Lavrnic D, Losen M, Vujic A, De Baets M, Hajdukovic LJ, Stojanovic V et al (2005) The features of myasthenia gravis with autoantibodies to MuSK. J Neurol Neurosurg Psychiatry 76(8):1099–1102

    Article  PubMed  CAS  Google Scholar 

  3. Evoli A, Lindstrom J (2011) Myasthenia gravis with antibodies to MuSK: another step toward solving mystery? Neurology 77(20):1783–1784

    Article  PubMed  Google Scholar 

  4. Sanders DB, El-Salem K, Massey JM, McConville J, Vincent A (2003) Clinical aspects of MuSK antibody positive seronegative MG. Neurology 60(12):1978–1980

    Article  PubMed  CAS  Google Scholar 

  5. Diaz-Manera J, Rojas-Garcia R, Gallardo E, Juarez C, Martinez-Domeno A, Martinez-Ramirez S et al (2007) Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan’s syndrome. Nat Clin Pract Neurol 3(7):405–410

    Article  PubMed  Google Scholar 

  6. Kostera-Pruszczyk A, Kwiecinski H (2009) Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy. J Neurol 256(10):1780–1781

    Article  PubMed  Google Scholar 

  7. Saulat B, Maertens P, Hamilton WJ, Bassam BA (2007) Anti-musk antibody after thymectomy in a previously seropositive myasthenic child. Neurology 69(8):803–804

    Article  PubMed  Google Scholar 

  8. Sanders DB, Juel VC (2008) MuSK-antibody positive myasthenia gravis: questions from the clinic. J Neuroimmunol 15(201–202):85–89

    Article  Google Scholar 

  9. O’Riordan JI, Miller DH, Mottershead JP, Pattison C, Hirsch NP, Howard RS (1998) Thymectomy: its role in the management of myasthenia gravis. Eur J Neurol 5(2):203–209

    Article  PubMed  Google Scholar 

  10. Hatanaka Y, Hemmi S, Morgan MB, Scheufele ML, Claussen GC, Wolfe GI et al (2005) Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG. Neurology 65(9):1508–1509

    Article  PubMed  CAS  Google Scholar 

  11. Pasnoor M, Wolfe GI, Nations S, Trivedi J, Barohn RJ, Herbelin L et al (2010) Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience. Muscle Nerve 41(3):370–374

    Article  PubMed  Google Scholar 

  12. Bhibhatbhan A, Kline G, Vincent A, Toth C (2007) Anti-MuSK myasthenia gravis presenting with Epstein–Barr virus-associated mononucleosis and immune-mediated diabetes mellitus. Muscle Nerve 36(2):264–266

    Article  PubMed  Google Scholar 

  13. Savino W, Berrih S (1984) Thymic extracellular matrix in myasthenia gravis. Lancet 2(8393):45–46

    Article  PubMed  CAS  Google Scholar 

  14. Berrih S, Morel E, Gaud C, Raimond F, Le Brigand H, Bach JF (1984) Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis. Neurology 34(1):66–71

    Article  PubMed  CAS  Google Scholar 

  15. Leite MI, Strobel P, Jones M, Micklem K, Moritz R, Gold R et al (2005) Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Ann Neurol 57(3):444–448

    Article  PubMed  Google Scholar 

  16. Gerli R, Paganelli R, Cossarizza A, Muscat C, Piccolo G, Barbieri D et al (1999) Long-term immunologic effects of thymectomy in patients with myasthenia gravis. J Allergy Clin Immunol 103(5 Pt 1):865–872

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

The authors declare that they have no conflict of interest.

Ethical standard

All human studies must state that they have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.

Author information

Authors and Affiliations

  1. National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK

    Sanjeev Rajakulendran, Jennifer Spillane & Robin S. Howard

  2. Institute of Neurology, UCL, Queen Square, London, WC1N 3BG, UK

    Sanjeev Rajakulendran, Jennifer Spillane & Robin S. Howard

  3. Imperial College Hospital NHS Trust, Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK

    Stuart Viegas

Authors
  1. Sanjeev Rajakulendran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stuart Viegas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jennifer Spillane
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robin S. Howard
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sanjeev Rajakulendran.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rajakulendran, S., Viegas, S., Spillane, J. et al. Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies. J Neurol 259, 2736–2739 (2012). https://doi.org/10.1007/s00415-012-6661-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-012-6661-9

Keywords

Search

Navigation